Shares Of Clovis Dip 70% After Announcing Delay In NDA Process By: TalkMarkets November 16, 2015 at 17:16 PM EST Clovis stock tanks as FDA notices that efficacy data for rociletinib is lacking and requests more. Read More >> Related Stocks: Astrazeneca Plc ADR Clovis Oncology Inc